Institutional Ownership
Biohaven Pharmaceutical Holding Co Ltd
CUSIP G11196105COMQ1 2026
13D / 13G Filings
8
Schedule 13D/13G on record
Beneficial Filers
3
Distinct reporting persons
Largest Stake
10.1%
Max % of class reported
Institutional Holders
1
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
8 filings · latest Jun 10, 2022
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Jun 10, 2022 | Capital International Investors | 13G/A | 2.2% | 1.57M | SEC |
| 2 | Jun 10, 2022 | Capital World Investors | 13G/A | 4.9% | 3.45M | SEC |
| 3 | May 10, 2022 | Capital World Investors | 13G/A | 10.0% | 7.08M | SEC |
| 4 | Feb 11, 2022 | Capital International Investors | 13G/A | 7.8% | 5.10M | SEC |
| 5 | Feb 11, 2022 | Capital World Investors | 13G/A | 9.4% | 6.18M | SEC |
| 6 | Feb 17, 2021 | Capital International Investors | 13G/A | 10.1% | 6.05M | SEC |
| 7 | Feb 16, 2021 | Capital World Investors | 13G | 7.8% | 4.65M | SEC |
| 8 | Feb 14, 2020 | Janus Henderson Group PLC | 13G/A | — | — | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Knoll Capital Management, LLC | 2.33M | $19.70M |